The story appears on

Page A3

February 3, 2023

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » News

More MNC regional HQs get certificates

ANOTHER batch of 20 regional headquarters and 10 research and development centers of multinational corporations were awarded official certificates in Shanghai.

Of the enterprises awarded certificates this time, most are in the city’s key industrial sectors, including six biomedical companies, five intelligent manufacturing firms, five in automobile and auto parts and seven in commerce, logistics and information service industries.

All of them are industry leaders, such as Merck from Germany, a leading global supplier in the life sciences industry. Germany’s renowned balancing machine manufacturer Schenck was also on the list, along with the world’s leading open biomedical technology platform WuXi Biological from Hong Kong. Shipping and logistics company Yusen Logistics from Japan was also awarded.

Among these headquarters of MNCs are seven recognized at the level of Greater China and above, which are, the Asia Pacific headquarters of Shenshi Biomedical under Hong Kong’s CStone Pharm, Tyson Foods’ Asia headquarters, and the Greater China headquarters of Siemens Healthineers and Novo Nordisk.

It was highlighted that in this batch, two are recognized as “business unit headquarters” — a new type of regional headquarters defined in the city’s revision of regulations in November 2022 to be recognized with criteria on the scale and proportion of operating revenues.

Also yesterday, 16 headquartered firms rooted in the city for 20 years, were given commemorative plaques.

Over the past two decades, more and more multinational enterprises have chosen Shanghai as their destination to set up their regional headquarters, sharing the fruits of China’s and Shanghai’s economic opening up and development.

Honeywell, for example, has built its Asia-Pacific regional headquarters in Shanghai as early as 2003. Even during the COVID-19 pandemic, the company has continued to increase its investment and expand production in China and Shanghai.

“Over the past 20 years, China has become Honeywell’s largest R&D center, production base and sales market in the world only after the United States,” said Yu Feng, president of Honeywell China.

“In the future, we will make new contributions to Shanghai’s high-quality development, as well as gain new benefits,” he added.

Fujifilm has also seen tremendous growth in terms of company size, staff number, business scope and tax payment after relocating its regional headquarters to Shanghai in 2002.

Starting from the sales of imaging products at the beginning of its settlement in the city, it now has five branches and nearly 15 business units nationwide, with businesses covering health care, life sciences, imaging, and optoelectronics.

“Twenty years on, looking back now on that decision, it was not only a right choice but also the optimal one,” said Zhu Dekang, vice president of Fujifilm (China) Investment Co.

In 2022, the actual use of foreign capital in Shanghai exceeded US$23.9 billion, hitting a record high in scale, while the city became home to more regional headquarters of multinational enterprises.

A total of 60 regional headquarters and 25 R&D centers of foreign companies were added last year, making their cumulative numbers reach 891 and 531, respectively, in the city.




 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend